Frontlight ResearchEarly access
Active, not recruitingNo phase
Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome
Key facts
- Who runs it
- Sohag University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 50 people, planned
- Started
- 1 Jan 2024
- Ended
- Apr 2026
- Type of study
- Observational
- Record updated
- 26 September 2025
Who can take part
- Age
- 2 years to 16 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- - Age between 2 and 16 years
- Diagnosis of steroid-dependent nephrotic syndrome (according to standard clinical criteria)
- Currently in remission or relapse while on steroid therapy
Who cannot take part
- - Children with congenital or secondary nephrotic syndrome
- Presence of other chronic kidney diseases
- Children with systemic diseases affecting bone or mineral metabolism
- Use of medications that affect calcium metabolism (other than steroids)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Prevelance of hypercalciurea in children with sterorid dependent nephrotic syndrome
The group in the trial
- Children with steroid dependent nephrotic syndrome
Participants will undergo urine analysis to measure calcium excretion in order to assess the prevalence of hypercalciuria. No experimental treatment will be given.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome in Sohag University Hospital
- Record updated
- 26 September 2025